Skip to main content

Table 4 Safety outcomes of patients receiving hyperacute stroke treatment

From: Establishing a hyperacute stroke service during the COVID-19 pandemic: our institution’s one year experience

 

Treatment group, n(%)

IVT

MT

IVT + MT

Overall

ICB at 24 h

 Asymptmatic

9 (90)

1(25)

3 (60)

13 (68.4)

 Symptomatic

1 (10)

3 (75)

2 (40)

6 (31.5)

 Mortality

3

3

5

11

  1. ICB Intracranial bleed
Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us